No picture, placeholder image
No picture, placeholder image
Institutt for helse- og omsorgsfag kirsten.marienhagen@uit.no Tromsø

Kirsten Marienhagen



  • Erlend Skaga, Cassia Bree Trewin-Nybråten, Pitt Niehusmann, Tom Børge Johannessen, Kirsten Marienhagen, Leif Oltedal m.fl.:
    Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
    Acta Oncologica 2024 DOI
  • Carsten Nieder, Kirsten Marienhagen, Roy Morten Kristensen, Torbjørn Sørbye, Lars Hoem :
    Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors
    Oncology Letters 2016 DOI
  • Jörn Schulz, Stein Olav Skrøvseth, Veronika Kristine Tømmerås, Kirsten Marienhagen, Fred Godtliebsen :
    A semiautomatic tool for prostate segmentation in radiotherapy treatment planning
    BMC Medical Imaging 2014 ARKIV / DOI
  • Carsten Nieder, Kirsten Marienhagen, Astrid Dalhaug, Gro Aandahl, Ellinor Haukland, Adam Pawinski :
    Prognostic models predicting survival of patients with brain metastases: Integration of lactate dehydrogenase, albumin and extracranial organ involvement
    Clinical Oncology 2014 DOI
  • Carsten Nieder, Kirsten Marienhagen, Astrid Dalhaug, Gro Aandahl, Ellinor Haukland, Adam Pawinski :
    Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
    Medical Oncology (MO) 2014 DOI
  • Carsten Nieder, Anca L. Grosu, Kirsten Marienhagen, Nikolaus H. Andratschke, Hans Geinitz :
    Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases
    Medical Oncology (MO) 2012 DOI
  • Carsten Nieder, Kirsten Marienhagen, Astrid Dalhaug, Jan Norum :
    Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
    Scientific World Journal 2012 ARKIV / DOI
  • Carsten Nieder, Kirsten Marienhagen, Hans Geinitz, Anca L. Grosu :
    Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?
    Journal of Cancer Research and Therapeutics 2011 ARKIV / DOI
  • Carsten Nieder, Sabrina T. Astner, Nikolaus H. Andratschke, Kirsten Marienhagen :
    Postoperative treatment and prognosis of patients with resected single brain metastasis: How useful are established prognostic scores?
    Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) 2011 DOI
  • Kirsten Marienhagen, Åslaug Helland, Terje Nordberg, Marianne Grønlie Guren, Eva Hofsli :
    Hva mener norske onkologer om sin arbeidssituasjon?
    Tidsskrift for Den norske legeforening 2010 DOI
  • Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, Cecilie E. Kiserud, Tonje Kristin Haug Nordenmark, Taran Annette Paulsen Hellebust m.fl.:
    Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
    BMJ Open 2023 ARKIV / DOI
  • Laura Toussaint, Petter Brandal, Anna Embring, Jacob Engellau, Morten Egeberg Evensen, Romualdas Griskeviskius m.fl.:
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncologica 2021 DOI
  • Einar Waldeland, Olav Dahl, Odd Harald Odland, Stein Olav Kvaløy, Jo-Åsmund Lund, Eirik Malinen m.fl.:
    Particle therapy in Norway - report from the national project group
    Radiotherapy and Oncology 2014

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →